Delaney Brendan 4
4 · IMMUNOMEDICS INC · Filed Nov 14, 2017
Insider Transaction Report
Form 4
IMMUNOMEDICS INCIMMU
Delaney Brendan
Chief Commercial Officer
Transactions
- Award
Stock Options (right to buy)
2017-11-10+150,000→ 150,000 totalExercise: $12.40Exp: 2024-11-10→ Common Stock, par value $0.01 per share (150,000 underlying)
Footnotes (1)
- [F1]The reporting person was granted stock options pursuant to the Company's 2014 Long-Term Incentive Plan. The stock options vest 25% on the first anniversary of the date of grant and 2.08333% on a monthly basis thereafter.